Editorials

How do mTOR inhibitors fit in the relapsed acute lymphoblastic leukemia treatment landscape?

Department of Pediatrics and Perlmutter Cancer Center NYU Langone Health
Department of Pediatrics and Perlmutter Cancer Center NYU Langone Health
Haematologica Early view Feb 3, 2022 https://doi.org/10.3324/haematol.2021.280395